NCT04122547View on ClinicalTrials.gov

Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Exacerbation CopdBronchiectasisLung Function Decreased
Interventions
DRUG

Roflumilast

Active drug

DRUG

Placebo

Placebo one tablet oral od

Trial Locations (1)

90110

Songklanagarind hospital, Songkhla

All Listed Sponsors
lead

Prince of Songkla University

OTHER

NCT04122547 - Efficacy of Roflumilast on Exacerbations in Patients With Non-cystic Fibrosis Bronchiectasis | Biotech Hunter | Biotech Hunter